Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and metformin on glycemic control in patients with type 2 diabetes. (Q51471806)
Jump to navigation
Jump to search
scientific article published on 7 May 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and metformin on glycemic control in patients with type 2 diabetes. |
scientific article published on 7 May 2007 |
Statements
1 reference
Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and metformin on glycemic control in patients with type 2 diabetes. (English)
1 reference
Barry J Goldstein
1 reference
Mark N Feinglos
1 reference
Jared K Lunceford
1 reference
Jeremy Johnson
1 reference
Debora E Williams-Herman
1 reference
Sitagliptin 036 Study Group
1 reference
7 May 2007
1 reference
1 reference
30
1 reference
1979-1987
1 reference
8
1 reference
Identifiers
1 reference
1 reference